(PharmaNewsWire.Com, June 14, 2017 ) According to the report Global Liquid Biopsy Market published by Market Data Forecast, the global market is projected to reach USD 1.75 billion by 2021 from USD 590.2 million in 2016, at a CAGR of 24.3%.
Liquid Biopsy is a test done on a sample of blood to look for cancer cells from a tumour that are circulating in the blood or for pieces of DNA from tumour cells that are in the blood. A liquid biopsy may be used to help find cancer at an early stage. It may also be used to help plan treatment or to find out how well treatment is working or if cancer has come back. Being able to take multiple samples of blood over time may also help doctors understand what kind of molecular changes are taking place in a tumour.
The factors influencing the Global Market for Liquid Biopsy Market, either positively or negatively are presented in the DROC analysis. Liquid biopsies are adopted due to the factors such as tolerability and patient convenience. Tissue biopsies cannot be done for few non-small cell lung cancers and liquid biopsy procedures are replacing tissue diagnosis procedures in such cases. Liquid biopsy research process involves a large amount of money and frequent clinical trials which is acting as a restraint for the market growth.
For granular level understanding, the Liquid Biopsy Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segments. By Cancer Type Lung Cancer Pancreatic Cancer Leukemia Other Visceral Cancers By Sample Type Blood Urine Plasma Saliva Cerebrospinal By Diagnostic Approach Circulating Tumour cells (CTC) Circulating Tumour DNA (ctDNA) RNA in exosomes Extra-Cellular Vesicles By End Users Reference Laboratories Hospital/Physician Laboratories Academic and Research Centers Other End Users
Geographically the market is segmented into North America (U.S.A. and Canada), Europe (U.K., Germany, Italy, France, and Spain), Asia-Pacific (India, China, Australia, South Korea and Japan), Latin America (Mexico, Argentina and Brazil), Middle east and Africa. All major action in the field of liquid biopsy is expected to emerge from North America and Europe region over the forecast period. However, increasing funding for private public partnerships in field of cancer research is expected to fuel the Asia-Pacific Market. North America Liquid Biopsy Market Europe Liquid Biopsy Market Asia-Pacific Liquid Biopsy Market Latin America Liquid Biopsy Market Middle East and Africa Liquid Biopsy Market
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, SysmexInostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU. Buy now: http://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
The Liquid Biopsy Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors thateffect the global market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Diagnostics Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
